154 related articles for article (PubMed ID: 37550206)
21. Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report.
Jo JC; Kim SJ; Lee HS; Eom HS; Lee SI; Park Y; Lee JO; Lee Y; Yhim HY; Yang DH; Byun JM; Kang HJ; Kim HJ; Shin HJ; Yoo KH; Suh C;
Ann Hematol; 2020 Feb; 99(2):223-228. PubMed ID: 31853704
[TBL] [Abstract][Full Text] [Related]
22. Application of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in mantle cell lymphoma.
Yang S; Fu L; AbuduRxiti M; Wu J; Wang Q; Qin Y; Zou X; Li H
Nucl Med Commun; 2020 May; 41(5):477-484. PubMed ID: 32168265
[TBL] [Abstract][Full Text] [Related]
23. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
[TBL] [Abstract][Full Text] [Related]
24. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
25. Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases.
Veselá P; Tonar Z; Sálek D; Vokurka S; Trněný M; Kodet R; Moulis M; Kašparová P; Vernerová Z; Velenská Z; Stříteský J; Michal M; Boudová L
Virchows Arch; 2014 Nov; 465(5):587-97. PubMed ID: 25048573
[TBL] [Abstract][Full Text] [Related]
26. Patterns of survival in mantle cell lymphoma.
Zucca E; Roggero E; Pinotti G; Pedrinis E; Cappella C; Venco A; Cavalli F
Ann Oncol; 1995 Mar; 6(3):257-62. PubMed ID: 7612491
[TBL] [Abstract][Full Text] [Related]
27. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.
Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T
Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of Clinical Characteivstics and Therapeutic Efticacy of 54 Patients with Mantle Cell Lymphoma].
Yang P; Liu YY; An R; Zhen JF; Pang M; Zhao W; Hu K; Wan W; Ke XY; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1336-1342. PubMed ID: 30295247
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study.
Igarashi T; Kobayashi Y; Ogura M; Kinoshita T; Ohtsu T; Sasaki Y; Morishima Y; Murate T; Kasai M; Uike N; Taniwaki M; Kano Y; Ohnishi K; Matsuno Y; Nakamura S; Mori S; Ohashi Y; Tobinai K;
Ann Oncol; 2002 Jun; 13(6):928-43. PubMed ID: 12123339
[TBL] [Abstract][Full Text] [Related]
30. [Change of NK Cell Number in Peripheral Blood of Patients with Mantle Cell Lymphoma and Its Clinical Significance].
Han DL; Han YY; Bao YL; Zhao WX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):772-776. PubMed ID: 28641633
[TBL] [Abstract][Full Text] [Related]
31. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
[No Abstract] [Full Text] [Related]
33. Mantle cell lymphoma: a Turkish Multi-Center Study.
Okay M; Meletli O; Kelkitli E; Malkan UY; Turgut M; Buyukasik Y; Tekin F; Demiroglu H; Goker H
J BUON; 2019; 24(5):2084-2089. PubMed ID: 31786879
[TBL] [Abstract][Full Text] [Related]
34. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
[TBL] [Abstract][Full Text] [Related]
35. [Cytarabine and hematopoietic cell transplantation for mantle cell lymphoma. Analysis of 20 patients].
Campbell J; Hurtado S; Kutz C; Soto K; Ernst D
Rev Med Chil; 2019; 147(1):9-17. PubMed ID: 30848759
[TBL] [Abstract][Full Text] [Related]
36. Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma.
Arcaini L; Lamy T; Walewski J; Belada D; Mayer J; Radford J; Jurczak W; Morschhauser F; Alexeeva J; Rule S; Cabeçadas J; Campo E; Pileri SA; Biyukov T; Patturajan M; Casadebaig Bravo ML; Trnĕný M;
Br J Haematol; 2018 Jan; 180(2):224-235. PubMed ID: 29193019
[TBL] [Abstract][Full Text] [Related]
37. Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.
Greenwell IB; Staton AD; Lee MJ; Switchenko JM; Saxe DF; Maly JJ; Blum KA; Grover NS; Mathews SP; Gordon MJ; Danilov AV; Epperla N; Fenske TS; Hamadani M; Park SI; Flowers CR; Cohen JB
Cancer; 2018 Jun; 124(11):2306-2315. PubMed ID: 29579328
[TBL] [Abstract][Full Text] [Related]
38. Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
Vose JM; Fu K; Wang L; Mansoor A; Stewart D; Cheng H; Smith L; Yuan J; Qureishi HN; Link BK; Cessna MH; Barr PM; Kahl BS; Mckinney MS; Khan N; Advani RH; Martin P; Goy AH; Phillips TJ; Mehta A; Kamdar M; Crump M; Pro B; Flowers CR; Jacobson CA; Smith SM; Stephens DM; Bachanova V; Jin Z; Wu S; Hernandez-Ilizaliturri F; Torka P; Anampa-Guzmán A; Kashef F; Li X; Sharma S; Greiner TC; Armitage JO; Lunning M; Weisenburger DD; Bociek RG; Iqbal J; Yu G; Bi C;
J Hematol Oncol; 2023 Dec; 16(1):122. PubMed ID: 38104096
[TBL] [Abstract][Full Text] [Related]
39. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
40. Matching-adjusted Indirect Comparisons of the Efficacy and Safety of Acalabrutinib Versus Other Targeted Therapies in Relapsed/Refractory Mantle Cell Lymphoma.
Telford C; Kabadi SM; Abhyankar S; Song J; Signorovitch J; Zhao J; Yao Z
Clin Ther; 2019 Nov; 41(11):2357-2379.e1. PubMed ID: 31699438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
